Nyxoah S.A. (NASDAQ:NYXH) Sees Large Increase in Short Interest

Nyxoah S.A. (NASDAQ:NYXH) was the target of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 100,200 shares, an increase of 27.2% from the February 13th total of 78,800 shares. Approximately 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 43,000 shares, the short-interest ratio is presently 2.3 days.

Nyxoah Price Performance

Shares of NASDAQ:NYXH opened at $10.60 on Wednesday. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21. Nyxoah has a 1 year low of $6.76 and a 1 year high of $18.95. The business has a fifty day simple moving average of $10.32 and a 200 day simple moving average of $9.22. The firm has a market cap of $361.04 million, a price-to-earnings ratio of -5.67 and a beta of 1.42.

Nyxoah (NASDAQ:NYXH) last posted its earnings results on Thursday, March 13th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.03). Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%. The company had revenue of $1.35 million for the quarter, compared to the consensus estimate of $2.02 million. As a group, sell-side analysts predict that Nyxoah will post -1.91 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nyxoah

Institutional investors have recently bought and sold shares of the stock. Kovack Advisors Inc. raised its holdings in Nyxoah by 100.0% during the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock valued at $160,000 after buying an additional 10,000 shares in the last quarter. Ameriprise Financial Inc. bought a new position in Nyxoah during the fourth quarter valued at about $135,000. Vestal Point Capital LP bought a new position in shares of Nyxoah in the fourth quarter worth about $23,394,000. Renaissance Technologies LLC bought a new position in shares of Nyxoah in the fourth quarter worth about $187,000. Finally, Geode Capital Management LLC increased its stake in shares of Nyxoah by 19.4% in the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock worth $137,000 after purchasing an additional 2,774 shares during the period.

Wall Street Analyst Weigh In

NYXH has been the subject of several recent analyst reports. Stifel Nicolaus decreased their target price on Nyxoah from $16.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, March 14th. HC Wainwright reiterated a “buy” rating and set a $17.00 price objective on shares of Nyxoah in a report on Friday, December 13th.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.